Judith V. Hobrath
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Computational Drug Discovery Methods, Cancer therapeutics and mechanisms, Biochemical and Molecular Research, Inflammatory mediators and NSAID effects
Most-Cited Works
- → High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv(2009)277 cited
- → Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition(2019)166 cited
- → Antituberculosis activity of the molecular libraries screening center network library(2009)151 cited
- → Endogenously produced nonclassical vitamin D hydroxy-metabolites act as “biased” agonists on VDR and inverse agonists on RORα and RORγ(2016)139 cited
- → A Novel Sulindac Derivative That Does Not Inhibit Cyclooxygenases but Potently Inhibits Colon Tumor Cell Growth and Induces Apoptosis with Antitumor Activity(2009)97 cited
- → High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv(2011)96 cited
- → Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols(2017)80 cited
- → Ligand-dependent downregulation of MR1 cell surface expression(2020)79 cited
- → Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma(2023)57 cited
- → Combining Computational Methods for Hit to Lead Optimization in Mycobacterium Tuberculosis Drug Discovery(2013)55 cited